Samsung Biologics inks biosimilar manufacturing deal with Pfizer
Samsung Biologics has entered into a strategic partnership for the long-term commercial manufacturing of Pfizer’s multi-product biosimilars portfolio.
Archives for June 12, 2023
Shionogi enrols first participant in SARS-CoV-2 therapy trial in Japan
Shionogi has enrolled the first participant in Japan in its phase 3 clinical trial of oral antiviral ensitrelvir to stop the post-infection progression of Covid-19.
Syncona launches new gene therapy company Beacon Therapeutics
Syncona has launched Beacon Therapeutics, a new ophthalmic gene therapy company with a purpose to restore and improve the vision of patients with retinal diseases, with £96 million Series A financing.